An investigation for investors in Veradigm Inc. (NASDAQ:MDRX) shares over potential securities laws violations by Veradigm Inc. was announced.

San Diego, CA -- (SBWire) -- 03/13/2023 --An investigation was announced for investors of Veradigm Inc. (NASDAQ: MDRX) shares over potential securities laws violations by Veradigm Inc.

Investors who purchased shares of Veradigm Inc. (NASDAQ: MDRX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Veradigm Inc. (NASDAQ: MDRX) concerning whether a series of statements by Veradigm Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Chicago, IL based Veradigm Inc., a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. On February 28, 2023, Veradigm Inc. announced that it "detected certain internal control failures related to revenue recognition that have occurred over the prior six quarters, resulting in a mis-statement to reported revenues during those periods." As a result, the Company reported that it expects "a reduction in revenue from continuing operations of approximately $20 million dollars in the aggregate from what it otherwise reported since the 3rd quarter of 2021 and expected to report for the 4th quarter of 2022." The company stated further that it is "continuing to evaluate the materiality of the mis-statement to determine if the full amount of this adjustment will flow through in the 4th quarter of 2022 or if prior periods will also require adjustment."

Shares of Veradigm Inc. (NASDAQ: MDRX) declined from $19.77 per share on January 13, 2023, to as low as $13.64 per share on March 10, 2023.

Those who purchased shares of Veradigm Inc. (NASDAQ: MDRX) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About The Shareholders Foundation
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.